Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Selective serotonine reuptake inhibitors prevents emotional lability in healthy subjects.

Scoppetta M, Di Gennaro G, Scoppetta C.

Eur Rev Med Pharmacol Sci. 2005 Nov-Dec;9(6):343-8.

PMID:
16479738
[PubMed - indexed for MEDLINE]
2.

Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.

Judge R, Parry MG, Quail D, Jacobson JG.

Int Clin Psychopharmacol. 2002 Sep;17(5):217-25.

PMID:
12177584
[PubMed - indexed for MEDLINE]
3.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

PMID:
18462573
[PubMed - indexed for MEDLINE]
Free Article
4.

Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man.

Schmitt JA, Ramaekers JG, Kruizinga MJ, van Boxtel MP, Vuurman EF, Riedel WJ.

J Psychopharmacol. 2002 Sep;16(3):207-14.

PMID:
12236626
[PubMed - indexed for MEDLINE]
5.

Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia.

Serrano-Blanco A, Pinto-Meza A, Suárez D, Peñarrubia MT, Haro JM; ETAPS Group (Efectivitat del Tractament antidepressiu en Atenció Primària de Salut).

Acta Psychiatr Scand Suppl. 2006;(432):39-47.

PMID:
17087814
[PubMed - indexed for MEDLINE]
6.

Rapid response of emotional incontinence to selective serotonin reuptake inhibitors.

Nahas Z, Arlinghaus KA, Kotrla KJ, Clearman RR, George MS.

J Neuropsychiatry Clin Neurosci. 1998 Fall;10(4):453-5.

PMID:
9813792
[PubMed - indexed for MEDLINE]
7.

[Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].

Bryois C, Rubin C, Zbinden JD, Baumann P.

Praxis (Bern 1994). 1998 Mar 4;87(10):345-8. Review. French.

PMID:
9545842
[PubMed - indexed for MEDLINE]
8.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
[PubMed - indexed for MEDLINE]
10.

Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients.

Yoshimura R, Mitoma M, Sugita A, Hori H, Okamoto T, Umene W, Ueda N, Nakamura J.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1034-7. Epub 2007 Mar 7.

PMID:
17459550
[PubMed - indexed for MEDLINE]
11.

Functional magnetic resonance imaging studies of emotional processing in normal and depressed patients: effects of venlafaxine.

Kalin NH, Davidson RJ, Irwin W, Warner G, Orendi JL, Sutton SK, Mock BJ, Sorenson JA, Lowe M, Turski PA.

J Clin Psychiatry. 1997;58 Suppl 16:32-9.

PMID:
9430507
[PubMed - indexed for MEDLINE]
12.

Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization.

Sheffield RE, Lo Sasso AT, Young CH, Way K.

Adm Policy Ment Health. 2002 Nov;30(2):121-39.

PMID:
12680617
[PubMed - indexed for MEDLINE]
14.

Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.

Ushiroyama T, Ikeda A, Ueki M.

J Med. 2004;35(1-6):151-62.

PMID:
18084873
[PubMed - indexed for MEDLINE]
15.

A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.

Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M.

Clin Neuropharmacol. 2007 Nov-Dec;30(6):326-34.

PMID:
18090457
[PubMed - indexed for MEDLINE]
16.

Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.

Nakao M, Takeuchi T, Nomura K, Teramoto T, Yano E.

Psychiatry Clin Neurosci. 2006 Oct;60(5):605-10.

PMID:
16958945
[PubMed - indexed for MEDLINE]
17.

Antidepressant therapy and C-reactive protein levels.

O'Brien SM, Scott LV, Dinan TG.

Br J Psychiatry. 2006 May;188:449-52.

PMID:
16648531
[PubMed - indexed for MEDLINE]
Free Article
18.

Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).

Mallinckrodt CH, Prakash A, Houston JP, Swindle R, Detke MJ, Fava M.

Neuropsychobiology. 2007;56(2-3):73-85. Epub 2007 Nov 23.

PMID:
18037817
[PubMed - indexed for MEDLINE]
19.

[Selective serotonin reuptake inhibitors in the therapy of various types of endogenous depressions].

Panteleeva GP, Abramova LI, Korenev AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2000;100(3):36-41. Russian.

PMID:
10758646
[PubMed - indexed for MEDLINE]
20.

Clinical practice guidelines for depression in young people.

Jureidini JN, Tonkin AL.

Med J Aust. 2003 Mar 17;178(6):300; author reply 300-2. No abstract available.

PMID:
12633493
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk